logo
15:57 Dec 12

Neuland Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
16079.00
-97.00 (-0.60%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Neuland Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
16079.00
-97.00 (-0.60%)
15:57 Dec 12
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

24/100
Expensive Valuation

Technical

48/100
Technically Neutral

Strength

9

Weakness

3

Opportunity

1

Threats

0

17.06 %

ROE %

11.93 %

ROA %

187.18

EPS

1,181.32

BVPS

17.61 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
951.08 1191.2 1558.58 1476.84 1329.98
Operating Expenses +
808.45 919.35 1095.99 1153.57 1095.61
Raw Material
437.55 487.74 632.43 574.81 581.33
Increase Decrease in Cost
-15.41 -9.51 -55.14 12.83 -57.03
Other Manufacturing Expense
131.36 135.56 156.51 162.87 0
Employee Cost
182.47 201.79 257.06 272 272.34
Miscellaneous Expenses
72.48 103.77 105.13 131.06 298.97
Operating Profit
142.63 271.85 462.59 323.27 234.37
Other Income
2.08 9.75 12.54 20.51 23.56
Depreciation
49.04 52.78 59.7 65.55 69.45
Interest
13.5 13.07 14 8.3 10.21
Profit before tax and exceptio..
82.16 215.75 401.44 269.93 178.27
Exceptional Items
0 0 0 76.4 55.78
PBT
82.16 215.75 401.44 346.33 122.49
Provision for Taxation
18.34 52.23 101.36 86.22 57.92
Net Profit
63.82 163.52 300.08 260.11 176.14
NET Profit after MI
63.82 163.52 300.08 260.11 176.14
EPS
49.74 127.45 233.89 202.74 137.28
Operating Profit Margin (%)
15 22.82 29.68 21.89 17.62
Net Profit Margin (%)
6.71 13.73 19.25 17.61 13.24

Neuland Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 32.60 32.70 32.70 32.70 32.60 32.70
FII 20.60 21.70 22.10 23.90 26.50 25.70
Public 14.00 12.00 11.40 9.50 6.70 6.80
Others 32.80 33.60 33.80 33.90 34.20 34.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: